NLS Pharmaceutics (NASDAQ:NLSP) Trading Up 0.7% – Time to Buy?

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) shares traded up 0.7% during trading on Wednesday . The stock traded as high as $3.23 and last traded at $2.71. 362,943 shares changed hands during trading, an increase of 123% from the average session volume of 162,739 shares. The stock had previously closed at $2.69.

NLS Pharmaceutics Stock Down 3.1 %

The company has a 50 day moving average of $4.07 and a 200 day moving average of $1.53.

Hedge Funds Weigh In On NLS Pharmaceutics

An institutional investor recently raised its position in NLS Pharmaceutics stock. Armistice Capital LLC raised its holdings in NLS Pharmaceutics Ltd. (NASDAQ:NLSP) by 6.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,311,000 shares of the company’s stock after acquiring an additional 139,000 shares during the period. Armistice Capital LLC owned approximately 19.62% of NLS Pharmaceutics worth $501,000 at the end of the most recent quarter.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).